Literature DB >> 26058493

Strain differences in the attenuation of bone accrual in a young growing mouse model of insulin resistance.

Elizabeth Rendina-Ruedy1, Jennifer L Graef1, McKale R Davis1, Kelsey D Hembree1, Jeffrey M Gimble2, Stephen L Clarke1, Edralin A Lucas1, Brenda J Smith3.   

Abstract

Skeletal fractures are considered a chronic complication of type 2 diabetes mellitus (T2DM), but the etiology of compromised bone quality that develops over time remains uncertain. This study investigated the concurrent alterations in metabolic and skeletal changes in two mouse strains, a responsive (C57BL/6) and a relatively resistant (C3H/HeJ) strain, to high-fat diet-induced glucose intolerance. Four-week-old male C57BL/6 and C3H/HeJ mice were randomized to a control (Con = 10 % kcal fat) or high-fat (HF = 60 % kcal fat) diet for 2, 8, or 16 weeks. Metabolic changes, including blood glucose, plasma insulin and leptin, and glucose tolerance were monitored over time in conjunction with alterations in bone structure and turn over. Elevated fasting glucose occurred in both the C57BL/6 and C3H/HeJ strains on the HF diet at 2 and 8 weeks, but only in the C57BL/6 strain at 16 weeks. Both strains on the HF diet demonstrated impaired glucose tolerance at each time point. The C57BL/6 mice on the HF diet exhibited lower whole-body bone mineral density (BMD) by 8 and 16 weeks, but the C3H/HeJ strain had no evidence of bone loss until 16 weeks. Analyses of bone microarchitecture revealed that trabecular bone accrual in the distal femur metaphysis was attenuated in the C57BL/6 mice on the HF diet at 8 and 16 weeks. In contrast, the C3H/HeJ mice were protected from the deleterious effects of the HF diet on trabecular bone. Alterations in gene expression from the femur revealed that several toll-like receptor (TLR)-4 targets (Atf4, Socs3, and Tlr4) were regulated by the HF diet in the C57BL/6 strain, but not in the C3H/HeJ strain. Structural changes observed only in the C57BL/6 mice were accompanied with a decrease in osteoblastogenesis after 8 and 16 weeks on the HF diet, suggesting a TLR-4-mediated mechanism in the suppression of bone formation. Both the C57BL/6 and C3H/HeJ mice demonstrated an increase in osteoclastogenesis after 8 weeks on the HF diet; however, bone turnover was decreased in the C57BL/6 with prolonged hyperglycemia. Further investigation is needed to understand how hyperglycemia and hyperinsulinemia suppress bone turnover in the context of T2DM and the role of TLR-4 in this response.

Entities:  

Keywords:  Fracture; Hyperglycemia; Inflammation; Insulin; Osteoblasts

Mesh:

Substances:

Year:  2015        PMID: 26058493     DOI: 10.1007/s00774-015-0685-z

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  69 in total

Review 1.  Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics.

Authors:  Sheila Collins; Tonya L Martin; Richard S Surwit; Jacques Robidoux
Journal:  Physiol Behav       Date:  2004-04

2.  In vivo assessment of bone quality in postmenopausal women with type 2 diabetes.

Authors:  Joshua N Farr; Matthew T Drake; Shreyasee Amin; L Joseph Melton; Louise K McCready; Sundeep Khosla
Journal:  J Bone Miner Res       Date:  2014-04       Impact factor: 6.741

3.  Genetic differences in the IGF-I gene among inbred strains of mice with different serum IGF-I levels.

Authors:  K Iida; C J Rosen; C Ackert-Bicknell; M O Thorner
Journal:  J Endocrinol       Date:  2005-09       Impact factor: 4.286

4.  Global prevalence and trends of overweight and obesity among preschool children.

Authors:  Mercedes de Onis; Monika Blössner; Elaine Borghi
Journal:  Am J Clin Nutr       Date:  2010-09-22       Impact factor: 7.045

5.  Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice.

Authors:  Mathieu Ferron; Marc D McKee; Robert L Levine; Patricia Ducy; Gérard Karsenty
Journal:  Bone       Date:  2011-04-29       Impact factor: 4.398

6.  First fracture is associated with increased risk of new fractures during growth.

Authors:  Ailsa Goulding; Ianthe E Jones; Sheila M Williams; Andrea M Grant; Rachael W Taylor; Patrick J Manning; John Langley
Journal:  J Pediatr       Date:  2005-02       Impact factor: 4.406

7.  Atherogenic high-fat diet reduces bone mineralization in mice.

Authors:  F Parhami; Y Tintut; W G Beamer; N Gharavi; W Goodman; L L Demer
Journal:  J Bone Miner Res       Date:  2001-01       Impact factor: 6.741

8.  Decreased insulin secretory capacity and normal pancreatic B-cell glucose sensitivity in non-obese patients with NIDDM.

Authors:  T W Van Haeften; W W Van Maarschalkerweerd; J E Gerich; E A Van der Veen
Journal:  Eur J Clin Invest       Date:  1991-04       Impact factor: 4.686

9.  Effect of obesity on estradiol level, and its relationship to leptin, bone maturation, and bone mineral density in children.

Authors:  K O Klein; K A Larmore; E de Lancey; J M Brown; R V Considine; S G Hassink
Journal:  J Clin Endocrinol Metab       Date:  1998-10       Impact factor: 5.958

10.  Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects.

Authors:  Sara M Reyna; Sangeeta Ghosh; Puntip Tantiwong; C S Reddy Meka; Phyllis Eagan; Christopher P Jenkinson; Eugenio Cersosimo; Ralph A Defronzo; Dawn K Coletta; Apiradee Sriwijitkamol; Nicolas Musi
Journal:  Diabetes       Date:  2008-07-15       Impact factor: 9.461

View more
  10 in total

1.  Influence of High-Fat Diet on Bone Tissue: An Experimental Study in Growing Rats.

Authors:  G Rezende Yanagihara; R Carminati Shimano; J Atsuko Tida; J Suzuki Yamanaka; S Yasuyo Fukada; J P Mardegan Issa; A C Shimano; J M Tavares
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

2.  Methodological considerations when studying the skeletal response to glucose intolerance using the diet-induced obesity model.

Authors:  Elizabeth Rendina-Ruedy; Brenda J Smith
Journal:  Bonekey Rep       Date:  2016-10-26

3.  A high-fat diet can affect bone healing in growing rats.

Authors:  Jéssica Suzuki Yamanaka; Gabriela Rezende Yanagihara; Bruna Leonel Carlos; Júnia Ramos; Brígida Batista Brancaleon; Ana Paula Macedo; João Paulo Mardegan Issa; Antônio Carlos Shimano
Journal:  J Bone Miner Metab       Date:  2017-05-17       Impact factor: 2.626

4.  Impaired glucose tolerance attenuates bone accrual by promoting the maturation of osteoblasts: Role of Beclin1-mediated autophagy.

Authors:  E Rendina-Ruedy; J L Graef; S A Lightfoot; J W Ritchey; S L Clarke; E A Lucas; B J Smith
Journal:  Bone Rep       Date:  2016-08-08

Review 5.  Toll-like Receptor 4, Osteoblasts and Leukemogenesis; the Lesson from Acute Myeloid Leukemia.

Authors:  Øystein Bruserud; Håkon Reikvam; Annette Katharina Brenner
Journal:  Molecules       Date:  2022-01-23       Impact factor: 4.411

Review 6.  Common Dietary Modifications in Preclinical Models to Study Skeletal Health.

Authors:  Elizabeth Rendina-Ruedy; Brenda J Smith
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-14       Impact factor: 6.055

7.  Supplier-origin mouse microbiomes significantly influence locomotor and anxiety-related behavior, body morphology, and metabolism.

Authors:  Aaron C Ericsson; Marcia L Hart; Jessica Kwan; Louise Lanoue; Lynette R Bower; Renee Araiza; K C Kent Lloyd; Craig L Franklin
Journal:  Commun Biol       Date:  2021-06-10

8.  Loss of Toll-Like Receptor 4 Function Partially Protects against Peripheral and Cardiac Glucose Metabolic Derangements During a Long-Term High-Fat Diet.

Authors:  Ellen E Jackson; Elisabeth Rendina-Ruedy; Brenda J Smith; Veronique A Lacombe
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

Review 9.  Role of Toll-Like Receptor 4 on Osteoblast Metabolism and Function.

Authors:  Ana Alonso-Pérez; Eloi Franco-Trepat; María Guillán-Fresco; Alberto Jorge-Mora; Verónica López; Jesús Pino; Oreste Gualillo; Rodolfo Gómez
Journal:  Front Physiol       Date:  2018-05-08       Impact factor: 4.566

Review 10.  Use of in vitro bone models to screen for altered bone metabolism, osteopathies, and fracture healing: challenges of complex models.

Authors:  Sabrina Ehnert; Helen Rinderknecht; Romina H Aspera-Werz; Victor Häussling; Andreas K Nussler
Journal:  Arch Toxicol       Date:  2020-09-10       Impact factor: 5.153

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.